denkapparat Operations’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
denkapparat Operations's PTGX Position: Q3 2026 in Review
denkapparat Operations opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 3,164 shares worth $446K. The stake represents 0.12% of the portfolio and ranks #315 among its holdings.
380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- denkapparat Operations held 3,164 shares of Protagonist Therapeutics worth $446K as of Q3 2026.
- Protagonist Therapeutics was a new denkapparat Operations position in Q3 2026.
- Protagonist Therapeutics made up 0.12% of denkapparat Operations's portfolio in Q3 2026, its #315 holding.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on denkapparat Operations's 13F filing for Q3 2026, filed 9 Nov 2026.